Form4insider filings, from the source

SEC Form 4 · accession 0001178579-26-000014

Fulcrum Therapeutics, Inc. · FULC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin Tang
10% Owner
Period of report
Jul 13, 2026
Accepted (ET)
Jul 15, 2026 · 7:50 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001680581

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 13, 2026P12,966$3.54A6,676,349ISee Footnote
Common StockF3,F2Jul 14, 2026P53,651$3.56A6,730,000ISee Footnote
Common StockF4,F2Jul 14, 2026P75,952$3.58A6,805,952ISee Footnote
Common StockF5,F2Jul 15, 2026P107,377$3.56A6,913,329ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses